Cargando…
Endothelial Phenotype Evoked by Low Dose Carvedilol in Pulmonary Hypertension
Background: The therapeutic benefits of β-blockers are well established in left heart failure. The Pulmonary Arterial Hypertension Treatment with Carvedilol for Heart Failure [PAHTCH] study showed safety and possible benefit of carvedilol in pulmonary arterial hypertension (PAH) associated right hea...
Autores principales: | Cheong, Hoi I, Farha, Samar, Park, Margaret M., Thomas, James D., Saygin, Didem, Comhair, Suzy A. A., Sharp, Jacqueline, Highland, Kristin B., Tang, W. H. Wilson, Erzurum, Serpil C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299019/ https://www.ncbi.nlm.nih.gov/pubmed/30619887 http://dx.doi.org/10.3389/fcvm.2018.00180 |
Ejemplares similares
-
Metabolic and Functional Evaluation of the Heart and Lungs in Pulmonary Hypertension by Gated 2-[18F]-Fluoro-2-deoxy-D-glucose Positron Emission Tomography
por: Saygin, Didem, et al.
Publicado: (2017) -
Coenzyme Q supplementation in pulmonary arterial hypertension
por: Sharp, Jacqueline, et al.
Publicado: (2014) -
Impaired Global Right Ventricular Longitudinal Strain Predicts Long-Term Adverse Outcomes in Patients with Pulmonary Arterial Hypertension
por: Park, Jae-Hyeong, et al.
Publicado: (2015) -
Mitochondrial Haplogroups and Risk of Pulmonary Arterial Hypertension
por: Farha, Samar, et al.
Publicado: (2016) -
Mast cell number, phenotype, and function in human pulmonary arterial hypertension
por: Farha, Samar, et al.
Publicado: (2012)